Lin Jizhen | Cancer immunotherapy | Best Researcher Award

Posted on by Neuroscientists

Prof. Lin Jizhen | Cancer immunotherapy | Best Researcher Award

Prof.  Lin Jizhen, Union Hospital, Fujian Medical University, China.

Dr. Jizhen Lin is a distinguished physician-scientist whose career has been defined by an unwavering dedication to the field of auditory molecular biology. With his foundational medical education from Fujian Medical University and advanced research training in biochemistry and molecular biology at the University of Minnesota, he has seamlessly blended clinical acumen with scientific innovation. His professional roles have evolved from intern and research fellow to Associate Professor and Laboratory Director, reflecting a career rich in mentorship, discovery, and leadership. His research has focused extensively on otitis media and the molecular mechanisms of hearing, contributing valuable insights into the pathophysiology and potential treatments of auditory disorders.

Profile

Scopus

 

📚 Early Academic Pursuits

Dr. Jizhen Lin’s academic journey began with a strong foundation in medicine at Fujian Medical University, Fuzhou, China, where he earned his M.D. in 1982 and an M.S. in Otolaryngology in 1987. His thirst for advanced knowledge and scientific discovery later brought him to the University of Minnesota, Minneapolis, where he immersed himself in the fields of biochemistry and molecular biology, further enriching his expertise and setting the stage for a robust research career in auditory sciences.

🧪 Professional Endeavors

Dr. Lin’s professional path has been marked by consistent dedication and a progressive climb through academic and research positions. His early clinical exposure as an intern at Union Hospital in Fujian laid the groundwork for his subsequent transition into research. Between 1992 and 1995, he served as an International Research Fellow at the Otitis Media Research Center (OMRC), University of Minnesota. He continued to make strides as a Research Scientist and Co-director of the Otopathology-Molecular Biology Laboratory, contributing significantly to auditory molecular biology. His leadership abilities culminated in his appointment as Director of the Auditory Molecular Biology Laboratory, and he has been serving as an Associate Professor in the Department of Otolaryngology at the University of Minnesota Medical School since 2008.

🔬 Contributions and Research Focus

Throughout his career, Dr. Lin has concentrated on unraveling the complexities of auditory molecular biology with a primary focus on otitis media, a prevalent childhood disease. His contributions have been instrumental in bridging clinical otolaryngology with molecular science, employing biochemical tools to investigate the pathogenesis of auditory disorders. His laboratory has played a critical role in advancing understanding of the genetic and cellular mechanisms that underpin hearing loss and middle ear infections, particularly through innovative translational approaches.

🏅 Accolades and Recognition

Dr. Lin’s relentless pursuit of scientific excellence and impactful research has earned him widespread recognition in the field of otolaryngology. His tenure as a Graduate Faculty advisor reflects not only his dedication to mentorship but also the high regard his peers and the academic community have for his expertise. While he may not be adorned with numerous public awards, the esteem in which he is held by colleagues and students alike underscores the quiet yet profound impact of his scholarly work.

🌍 Impact and Influence

The influence of Dr. Lin’s research extends beyond the laboratory, as his findings have contributed meaningfully to clinical practices and therapeutic approaches in otolaryngology. By identifying key molecular targets and pathways involved in auditory disorders, his work continues to shape the development of novel diagnostics and treatments. Furthermore, his role in international research collaborations underscores his commitment to knowledge exchange and global scientific advancement.

🧠 Legacy and Future Contributions

Dr. Lin’s legacy is firmly rooted in the integration of molecular science with clinical otolaryngology, a field he has helped shape through decades of dedicated research and academic mentorship. As a mentor to future scientists and a contributor to critical advancements in auditory health, he remains a cornerstone in the bridge between basic science and patient care. Looking forward, his ongoing work in auditory molecular biology is poised to further uncover the mechanisms of hearing and hearing loss, promising new frontiers in medical intervention and auditory health.

🧬 Lifelong Commitment to Hearing Science

Dr. Lin’s career embodies a lifelong commitment to auditory science, from the clinic to the lab. His seamless blend of clinical knowledge, molecular expertise, and research leadership has fostered a rich legacy in otolaryngology. With ongoing contributions to scientific understanding and future discoveries on the horizon, Dr. Lin continues to inspire a generation of researchers and clinicians dedicated to improving hearing health worldwide.

Publication

  1. Title: Cell-free transcription amplification-based split-type electrochemical sensor using enzyme-linked magnetic microbeads for minimal residual leukemia detection
    Authors: Luying Yu, Jinyuan Chen, Huanjiao Weng, … Xinhua Lin, Guangxian Zhong
    Year: 2025

 

  1. Title: Antibody screening-assisted multichannel nanoplasmonic sensing chip based on SERS for viral screening and variants identification
    Authors: Yi Liu, Huanjiao Weng, Zhiwei Chen, … Shangyuan Feng, Duo Lin
    Year: 2025

 

  1. Title: tRNA methyltransferase DNMT2 promotes hepatocellular carcinoma progression and enhances Bortezomib resistance through inhibiting TNFSF10
    Authors: Junzhong Lai, Linqin Chen, Qiumei Li, … Jizhen Lin, Qi Chen
    Year: 2025

 

  1. Title: Carrimycin ameliorates lipopolysaccharide and cecal ligation and puncture-induced sepsis in mice
    Authors: Junzhong Lai, Jiadi Liang, Kunsen Chen, … Qi Chen, Jizhen Lin
    Year: 2024

 

  1. Title: B7H3 targeting gold nanocage pH-sensitive conjugates for precise and synergistic chemo-photothermal therapy against NSCLC
    Authors: Bing Chen, Kaifan Zheng, Shubin Fang, … Jizhen Lin, Xinhua Lin
    Year: 2023

 

  1. Title: A drug-delivery depot for epigenetic modulation and enhanced cancer immunotherapy
    Authors: Junzhong Lai, Jiadi Liang, Yong Zhang, … Jizhen Lin, Qi Chen
    Year: 2023

 

  1. Title: Ultrasensitive detection of SARS-CoV-2 antigen using surface-enhanced Raman spectroscopy-based lateral flow immunosensor
    Authors: Shuxia Lai, Yi Liu, Shubin Fang, … Jizhen Lin, Shangyuan Feng
    Year: 2023

 

  1. Title: Retraction Note to: Linc00210 drives Wnt/β-catenin signaling activation and liver tumor progression through CTNNBIP1-dependent manner
    Authors: Xiaomin Fu, Xiaoyan Zhu, Fujun Qin, … Qinxian Zhang, Quanli Gao
    Year: Not specified

 

  1. Title: SFPQ Promotes Lung Cancer Malignancy via Regulation of CD44 v6 Expression
    Authors: Libang Yang, Jiangbo Yang, Blake A. Jacobson, … Craig A. Henke, Jizhen Lin
    Year: 2022

 

✅ Conclusion

Dr. Lin’s lifelong commitment to understanding the science of hearing has positioned him as a pioneering figure in otolaryngology. Through decades of research, academic guidance, and clinical collaboration, he has built a legacy rooted in translational science and patient-centered innovation. His work continues to influence both basic research and clinical practice, promising a future where auditory health is better understood and more effectively managed. As a scientist, mentor, and innovator, Dr. Lin stands as an enduring contributor to the advancement of hearing science.

Magdalena Budzyń | Immunology | Women Researcher Award

Posted on by Neuroscientists

Assist. Prof. Dr. Magdalena Budzyń | Immunology | Women Researcher Award

Assist. Prof. Dr. Magdalena Budzyń, Poznan University of Medical Sciences, Poland.

Dr. Magdalena Budzyń is an accomplished researcher and educator specializing in cardiovascular diseases and laboratory diagnostics. With a strong academic foundation from Poznan University of Medical Sciences, she earned her Ph.D. in Medical Sciences and later achieved the prestigious habilitated doctor qualification. Her research focuses on endothelial damage markers and their role in cardiovascular conditions, contributing valuable insights into disease mechanisms. As an Assistant Professor, she has been dedicated to both scientific discovery and mentoring future medical professionals.

Profile

Orcid

Early Academic Pursuits 🎓

Born on April 4, 1982, Dr. Magdalena Budzyń embarked on her academic journey with a passion for medical sciences. Her educational path began at Poznan University of Medical Sciences, where she pursued an in-depth study of laboratory diagnostics. She completed her Ph.D. in Medical Sciences between 2009 and 2013, focusing on the intricate balance between leukocyte elastase and its inhibitor alpha1-antitrypsin in chronic venous insufficiency. With an insatiable curiosity for cardiovascular research, she further advanced her academic credentials by earning a habilitated doctor degree in 2022, exploring circulating markers of endothelial damage and their clinical implications in cardiovascular diseases.

Professional Endeavors 🏅

Dr. Budzyń’s professional career has been a testament to her dedication to medical research and education. She has been an integral part of Poznan University of Medical Sciences since 2007, serving as an Assistant Professor. Prior to that, she gained valuable experience at Poznan Veterinary Institute as a Technical Assistant, where she honed her laboratory and analytical skills. Her expertise in laboratory medicine and medical chemistry has made her a respected academic in her field, contributing significantly to both research and teaching.

Contributions and Research Focus 🔬

Her research primarily revolves around cardiovascular diseases, with a particular emphasis on endothelial damage markers. By investigating the role of these biomarkers, she has provided critical insights into the pathophysiology of vascular disorders. Her work has contributed to the understanding of chronic venous insufficiency and how leukocyte elastase imbalance impacts disease progression. Additionally, her studies in laboratory diagnostics have strengthened the role of clinical biomarkers in predicting and managing cardiovascular conditions.

Accolades and Recognition 🏆

Dr. Budzyń’s academic excellence has been recognized through her habilitated doctor qualification, a prestigious milestone in her career. Her contributions to medical sciences have been acknowledged within the scientific community, as she continues to shape the field of cardiovascular research. Her role as an educator and mentor further amplifies her influence, guiding students toward meaningful research endeavors in laboratory medicine and diagnostics.

Impact and Influence 🌍

Beyond academia, Dr. Budzyń’s research has a profound impact on the medical field, particularly in improving diagnostic tools for cardiovascular diseases. Her findings contribute to enhanced patient care by identifying key biomarkers that aid in early disease detection and treatment planning. She actively collaborates with researchers and medical professionals, ensuring that her work bridges the gap between scientific discovery and clinical application.

publication

  • Significance of the monocyte CCR2-CCL2 axis in triple-negative breast cancer
    Authors: Magdalena Budzyń, Agata Kubicka, Elżbieta Kaja, Witold Kycler, Joanna Załuska-Kusz, Jacek J. Brzeziński, Marcelina Sperling, Alicja Bukowska, Joanna Grupińska
    Year: 2025

 

  • Nutritional Behaviors, Vitamin Supplementation and Physical Activity among Polish Adults during the COVID-19 Pandemic
    Authors: Bogna Gryszczyńska, Magdalena Budzyń, Joanna Grupińska, Magdalena Paulina Kasprzak, Agnieszka Gryszczyńska
    Year: 2022

 

  • Beneficial Effects of Oral Nutritional Supplements on Body Composition and Biochemical Parameters in Women with Breast Cancer Undergoing Postoperative Chemotherapy: A Propensity Score Matching Analysis
    Authors: Joanna Grupińska, Magdalena Budzyń, Kalina Maćkowiak, Jacek Jakub Brzeziński, Witold Kycler, Ewa Leporowska, Bogna Gryszczyńska, Magdalena Paulina Kasprzak, Maria Iskra, Dorota Formanowicz
    Year: 2021

 

  • Association between clinicopathological features of breast cancer with adipocytokine levels and oxidative stress markers before and after chemotherapy
    Authors: Magdalena Budzyń
    Year: 2021

 

  • Changes in the Nrf2/Keap1 Ratio and PON1 Concentration in Plasma of Patients Undergoing the Left Main Coronary Artery Stenting
    Authors: Magdalena Budzyń
    Year: 2020

 

  • Selected Atherosclerosis-Related Diseases May Differentially Affect the Relationship between Plasma Advanced Glycation End Products, Receptor sRAGE, and Uric Acid
    Authors: Bogna Gryszczyńska, Magdalena Budzyń, Dorota Formanowicz, Maria Wanic-Kossowska, Piotr Formanowicz, Wacław Majewski, Maria Iskra, Magdalena P. Kasprzak
    Year: 2020

 

  • Association between Advanced Glycation End Products, Soluble RAGE Receptor, and Endothelium Dysfunction, Evaluated by Circulating Endothelial Cells and Endothelial Progenitor Cells in Patients with Mild and Resistant Hypertension
    Authors: Magdalena Budzyń
    Year: 2019

 

  • The Potential Role of Circulating Endothelial Cells and Endothelial Progenitor Cells in the Prediction of Left Ventricular Hypertrophy in Hypertensive Patients
    Authors: Magdalena Budzyń
    Year: 2019

 

  • Advanced Oxidation Protein Products and Carbonylated Proteins Levels in Endovascular and Open Repair of an Abdominal Aortic Aneurysm: The Effect of Pre-, Intra-, and Postoperative Treatment
    Authors: Bogna Gryszczyńska, Magdalena Budzyń, Dorota Formanowicz, Piotr Formanowicz, Zbigniew Krasiński, Natalia Majewska, Maria Iskra, Magdalena P. Kasprzak
    Year: 2019

 

Conclusion

Dr. Budzyń’s contributions to medical sciences extend beyond academia, influencing the fields of laboratory diagnostics and cardiovascular research. Her work has significantly improved the understanding of endothelial dysfunction and biomarker-based diagnostics, paving the way for better clinical applications. With her ongoing dedication to research and education, she continues to inspire the next generation of scientists while striving to make impactful advancements in medical science.

Basanta Kumar das | Immunology | Best Researcher Award

Posted on by Neuroscientists

Dr. Basanta Kumar das | Immunology | Best Researcher Award

Dr. Basanta Kumar das, Central Inland Fisheries Research Institute,  India.

Dr. Basanta Kumar Das is a distinguished fisheries scientist and Director of ICAR-Central Inland Fisheries Research Institute (CIFRI), Kolkata. Born in Odisha in 1966, he pursued his Ph.D. from Orissa University of Agriculture and Technology and later completed his postdoctoral research at FRS Marine Lab, Scotland. Throughout his career, he has significantly contributed to disease management in open-water fish ecosystems, aquaculture health management, molecular epidemiology of fish diseases, and antiviral gene expression studies in carps. He has also developed medicines for ornamental fish diseases, immunostimulants, and bioactive compounds from algae and plant derivatives.

Profile

Google Scholar

 

Early Academic Pursuits 🎓

Born on March 20, 1966, in Athilabaj, District Balasore, Odisha, Dr. Basanta Kumar Das embarked on an academic journey that laid the foundation for his remarkable contributions to fisheries science. He pursued his education at the Orissa University of Agriculture and Technology, earning his Ph.D. in 1998. His relentless thirst for knowledge led him to a prestigious post-doctoral fellowship at the FRS Marine Lab in Aberdeen, Scotland, UK (2006–2007), where he deepened his expertise in aquatic health and disease management. His early academic pursuits cemented his position as a leading authority in fisheries research, blending traditional knowledge with modern scientific approaches.

Professional Endeavors and Leadership 🌊

Dr. Das has dedicated his career to revolutionizing inland fisheries and aquaculture. Currently serving as the Director of ICAR-Central Inland Fisheries Research Institute (CIFRI), Kolkata, he has spearheaded numerous initiatives to enhance aquatic resource management. Beyond his directorial role, he serves as the President of the Inland Fisheries Society of India, President of the Professional Fisheries Graduates Forum, and President of the Orissa Fisheries College Alumni Association. These leadership positions reflect his unwavering commitment to fostering scientific communities and strengthening professional networks in fisheries and aquatic sciences.

Contributions and Research Focus 🔬

Dr. Das’s research has been instrumental in addressing critical challenges in fisheries science. His expertise spans diverse areas, including disease management in open-water fish ecosystems, health management in aquaculture, and molecular epidemiological studies of fish diseases. His groundbreaking work in anti-viral gene expression studies of carps has opened new frontiers in aquatic disease control. Additionally, he has contributed significantly to the development of medicines for ornamental fish diseases, innovative immunostimulants, and bioactive compounds derived from algae and plant derivatives. His pioneering research on enclosure culture in inland open waters has transformed sustainable fisheries management, providing innovative solutions for fish conservation and productivity.

Accolades and Recognition 🏆

Dr. Das’s illustrious career has been adorned with numerous prestigious awards. He received the Jawaharlal Nehru Award for outstanding postgraduate research from ICAR, followed by the Lal Bahadur Shastri Young Scientist Award (1999–2000). His excellence in fisheries science earned him the Dr. M.S. Swaminathan Award (2011) and the Krushi Ratna Award (2016). His remarkable contributions were further acknowledged with the Eminent Zoologist of the Year Award (2017), the Ganesh Chandra Vidyarthi Award (2018), and the Best Annual Report Award (2019). In recognition of his institutional leadership, ICAR-CIFRI received the Sardar Patel Outstanding ICAR Institution Award (2020) under his direction. The pinnacle of his accolades includes the Rafi Ahmed Kidwai Award (2020) for outstanding research in agricultural sciences and the Agri-Food Empowering India Award (2021).

Impact and Influence on the Global Scientific Community 🌍

Dr. Das has built strong international collaborations, expanding the reach of Indian fisheries research to the global stage. He has established vital partnerships with WorldFish, FAO, NACA, GIZ, SAARC, BOBP, IUCN, World Bank, and leading universities such as RMIT University, University of Manitoba, University of Waterloo, and University of Aberdeen. His role in policy advisory and scientific development has helped shape sustainable aquaculture practices worldwide. Additionally, his commitment to academic mentorship is reflected in his guidance of 25 Ph.D. scholars, 35 Master’s students, two postdoctoral researchers, and two international scholars. His contribution to fisheries education and scientific discourse is further amplified by 13 MoUs with government departments, commercial enterprises, and research collaborations.

Scientific Contributions and Publications 📚

Dr. Das’s prolific research output stands as a testament to his enduring impact on fisheries science. With over 375 international publications and 8,286 citations, his work has significantly influenced the global scientific community. His extensive research on fish diseases, bioactive compounds, and molecular diagnostics has provided critical insights into improving fish health management and enhancing aquaculture sustainability. His contributions continue to be referenced by researchers, policymakers, and industry leaders worldwide, reinforcing his position as a thought leader in aquatic sciences.

Legacy and Future Contributions 🚀

As a visionary in fisheries science, Dr. Basanta Kumar Das’s contributions extend beyond research and academia. His work has set new benchmarks in disease management, aquaculture sustainability, and molecular epidemiology. His leadership in inland fisheries research will continue to drive innovations in biotechnological advancements for disease prevention, eco-friendly aquaculture techniques, and sustainable fisheries management. With a steadfast commitment to environmental conservation and scientific excellence, his legacy will inspire future generations of researchers to explore the uncharted depths of aquatic sciences and contribute to a more resilient and productive fisheries sector.

Publication

 

  • Effect of Achyranthes aspera on the immunity and survival of Labeo rohita infected with Aeromonas hydrophila
    Authors: YV Rao, BK Das, P Jyotyrmayee, R Chakrabarti
    Year: 2006

 

  • Toxicity of cypermethrin in Labeo rohita fingerlings: biochemical, enzymatic and haematological consequences
    Authors: BK Das, SC Mukherjee
    Year: 2003

 

  • Effect of Allium sativum on the immunity and survival of Labeo rohita infected with Aeromonas hydrophila
    Authors: S Sahu, BK Das, BK Mishra, J Pradhan, N Sarangi
    Year: 2007

 

  • Effect of long term administration of dietary β-glucan on immunity, growth and survival of Labeo rohita fingerlings
    Authors: CK Misra, BK Das, SC Mukherjee, P Pattnaik
    Year: 2006

 

  • Effect of Magnifera indica kernel as a feed additive on immunity and resistance to Aeromonas hydrophila in Labeo rohita fingerlings
    Authors: S Sahu, BK Das, J Pradhan, BC Mohapatra, BK Mishra, N Sarangi
    Year: 2007

 

  • Effect of multiple injections of β-glucan on non-specific immune response and disease resistance in Labeo rohita fingerlings
    Authors: CK Misra, BK Das, SC Mukherjee, P Pattnaik
    Year: 2006

 

  • Spatial distribution of meso and microplastics in the sediments of river Ganga at eastern India
    Authors: DJ Sarkar, SD Sarkar, BK Das, RK Manna, BK Behera, S Samanta
    Year: 2019

 

  • Emergence of tilapia lake virus associated with mortalities of farmed Nile tilapia Oreochromis niloticus (Linnaeus 1758) in India
    Authors: BK Behera, PK Pradhan, TR Swaminathan, N Sood, P Paria, A Das, …
    Year: 2018

 

  • A histopathological study of carp (Labeo rohita) exposed to hexachlorocyclohexane
    Authors: BK Das, SC Mukherjee
    Year: 2000

 

  • A predator–prey interaction model with self and cross-diffusion
    Authors: B Dubey, B Das, J Hussain
    Year: 2001

 

Conclusion

Dr. Basanta Kumar Das’s legacy in fisheries science is marked by groundbreaking research, transformative leadership, and unwavering dedication to advancing aquatic health, sustainable fisheries, and innovative disease management solutions. His scientific endeavors have revolutionized inland aquaculture, bridging the gap between traditional fisheries practices and modern molecular research. Through his mentorship, institutional leadership, and global collaborations, he continues to shape the next generation of fisheries scientists while working toward sustainable and eco-friendly aquaculture solutions. His lifelong commitment to fisheries research ensures that his contributions will have a lasting impact on the global fisheries sector, environmental conservation, and food security.